lobbying_activities: 2968220

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2968220	e682d95a-7fdc-437e-b0c8-bcc485de5708	Q1	HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC	17966	EMERGENT BIOSOLUTIONS	2023	first_quarter	DIS	Draft Department of Health and Human Services Appropriations Bill, 2024 - funding and policy for development, acquisition, and stockpiling of medical countermeasures, including Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Agency (BARDA), and Project BioShield; Opioid and heroin addiction legislation, naloxone access and awareness, and prescribing guidelines; State opioid response (SOR) grant funding proposals; Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act - P.L. 116-22; Draft National Defense Authorization bill (NDAA), 2024 - provisions related to biological and chemical defense and access to Naloxone.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2023-04-19T11:24:51-04:00